MediConnect
MediConnect
Token: MEDI


Future of Medicine Online

ICO dates
Start date: 2019-02-06
End date:

Registrated in: UK

Platform: STRATIS
Type: STRATIS

PREMIUM ICO

MediConnect categories
Health
MediConnect token sale
KYC passing required No | Whitelist Yes | Restriction for countries No
Price 1 MEDI = 0.1 USD
MediConnect news, social
MediConnect search trends in Google

MediConnect Roadmap

1
Q1 2018
Conceived Idea and scoped out requirements of a Prescription Drug Addiction Database.
2
Q2 2018
Agreed blockchain platform partnership with Stratis.
3
Q3 2018
Presented idea of a regional trial of East Midlands Pharmacies with newly formed Nottingham Addiction Safeguarding Committee.
4
Q4 2018
Jason Timms appointed chair of the official Prescription Drug Addiction (PDA) Working Group with the BBFA to tackle over prescribing, drug recalls, counterfeit drug reduction.

Agreed contract start date with ASC Nottingham for Q2 2019 and the onboarding of 2 Pharmacies to MediConnect.

Attended all Chairperson Meeting of the BBFA working groups to look at collaborative opportunities of the PDA on legal, identity, master data, assurance and Cybersecurity working groups.
5
Q1 2019
ICO Public Sale.

PDA Working Group meeting – Invites to attend to CQC, MHRA, GPhC, LPC, Pharma wholesale and retail industry.
6
Q2 2019
Commence contract with the ASC to support the Nottingham Trial and UK roll out programme.

Tower Pharmacy & UK Meds will be first 2 Pharmacies on the ASC blockchain solution from MediConnect.

6 other Pharmacies will be integrated, including 1 NHS Hospital outpatient dispensing pharmacy.
7
Q3 2019
Collaboration with Local Pharmacy Groups and membership committee to inform on pilot and expand reach to 20 further pharmacies in Nottingham, Derby & Leicester.

Partnership with Pharmacy Wholesaler – implementation of drug recall and counterfeit medication system.
8
Q4 2019
Publish trial research and outcomes – present at PDA meeting to CQC, MHRA. GPhC, LPC and Industry.
9
Q1 2020
The MediConnect platform will demonstrate an improved duty of care and detection that will see a reduction in pharmacy insurance for Pharmacies.
10
Q2 2020
Will see the recruitment of 500 UK Pharmacies join MediConnect through the expansion of the ASC membership in the UK.
11
Q3 2020
Aim for MediConnect to be the Industry standard solution for traceability of drugs for recall and counterfeit medication detection.
12
Q4 2020
The ASC achieves it’s goal of UK Pharmacies required to be members of the ASC and the MediConnect platform is used by all UK pharmacies
Chris Trew
Chris Trew
Strategic Advisor
CEO and Founder of Stratis Group Ltd
Dexter Blackstock
Dexter Blackstock
Director
Eddie Dandy
Eddie Dandy
Superintendent Pharmacist
Jason Timms
Jason Timms
PHZ Group Owner & Visionary
Joe Soiza
Joe Soiza
UK Meds Owner and Healthcare Visionary
Samuel Ogunsalu
Samuel Ogunsalu